Abstract
Radiation resistant squamous cell carcinoma of the head and neck cell line JSQ-3 carries a mutant form of tumor suppressor gene p53. Treatment of these cells with an adenoviral vector containing wild-type p53 (Av1p53) was able to inhibit their growth in vitro and in vivo while having no effect on normal cells. More significantly, introduction of wtp53 also reduced the radiation-resistance level of this cell line in vitro, in a viral dose-dependent manner. Furthermore, this radiosensitization also carried over to the in vivo situation where the response of JSQ-3 cell-induced mouse xenografts to radiotherapy was markedly enhanced after treatment with Av1p53. Complete, long-term regression of the tumors for up to 162 days was observed when a single dose of Av1p53 was administered in combination with ionizing radiation, demonstrating the effectiveness of this combination of gene therapy and conventional radiotherapy. This sensitization of tumors to radiation therapy by replacement of wtp53 could significantly decrease the rate of recurrence after radiation treatment. Since radiation is one of the most prevalent forms of adjunctive therapy for a variety of cancers, these results have great relevance in moving toward an improved cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pirollo, K., Hao, Z., Rait, A. et al. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 14, 1735–1746 (1997). https://doi.org/10.1038/sj.onc.1201116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201116
Keywords
This article is cited by
-
Advances in radiotherapy and immunity in hepatocellular carcinoma
Journal of Translational Medicine (2023)
-
Molecular fingerprinting of radiation resistant tumors: Can we apprehend and rehabilitate the suspects?
BMC Cancer (2009)
-
High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation
Journal of Cancer Research and Clinical Oncology (2009)
-
Adenovirus-mediated p53 gene transfer sensitizes hepatocellular carcinoma cells to heavy-ion radiation
Journal of Gastroenterology (2007)
-
Pre-irradiation with low-dose 12C6+ beam significantly enhances the efficacy of AdCMV-p53 gene therapy in human non-small lung cancer
Science in China Series G: Physics, Mechanics and Astronomy (2007)